Drug Approval | January 20, 2024
Shilpa Medicare receives Europe approval for Amifampridine Tablets, 10 mg
This product has sales of about US$ 20 million in Europe
This product has sales of about US$ 20 million in Europe
Glenmark Life Sciences will manufacture API in the therapeutic area of urinary anti-spasmodic, to supply to the global innovator
Febuxostat Tablets (RLD Uloric) had estimated annual sales of US$ 27 million in the U.S. (IQVIA MAT November 2023)
Both these innovations are aimed at reducing the risk of relapse post CAR T cell therapy
Pimavanserin is an atypical antipsychotic indicated for the treatment of hallucinations and delusions associated with Parkinson disease psychosis
Collaboration streamlines patient access to oncology clinical trials
This turn valve is considered revolutionary because it supports back-to-back drug infusion through the same device
Approval based on a separate phase III trial among Chinese patients reinforcing mepolizumab’s efficacy and safety data
Inducts advanced AI-Powered 24x7 remote patient monitoring system
The Aptivate Champion Run witnessed an enthusiastic participation of over 4,000 Mumbaikars
Subscribe To Our Newsletter & Stay Updated
